Outcomes of Sequential Therapy With Tenofovir Alafenamide After Long-term Entecavir-Reference-Cited by-同舟云学术

Outcomes of Sequential Therapy With Tenofovir Alafenamide After Long-term Entecavir

Published:2021-02-02 Issue:6 Volume:116 Page:1264-1273
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterol

Author:

Nguyen Mindie H.,Atsukawa Masanori,Ishikawa Toru,Yasuda Satoshi,Yokohama Keisuke,Trinh Huy N.,Arai Taeang,Fukunishi Shinya,Ogawa Eiichi,Hsu Yao-Chun,Maeda Mayumi,Dang Hansen,Tseng Cheng-Hao,Takahashi Hirokazu,Jun Dae Won,Watanabe Tsunamasa,Chuma Makoto,Nozaki Akito,Kawada Norifumi,Cheung Ramsey,Enomoto Masaru,Takaguchi Koichi,Toyoda Hidenori

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference41 articles.

1. Tenofovir alafenamide in the treatment of chronic hepatitis B: Design, development, and place in therapy;Ogawa;Drug Des Devel Ther,2017

2. Tenofovir alafenamide as compared to tenofovir disoproxil fumarate in the management of chronic hepatitis B with recent trends in patient demographics;Hsu;Expert Rev Gastroenterol Hepatol,2017

3. A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naive chronic hepatitis B in South Korea;Kim;J Hepatol,2019

4. Incidence and predictors of retreatment in chronic hepatitis B patients after discontinuation of entecavir or tenofovir treatment;Ma;PLoS One,2019

5. Japan Society of Hepa guidelines for the management of hepatitis B virus infection: 2019 update;Tanaka;Hepatol Res,2020

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improvement in renal function after switching from entecavir to tenofovir alafenamide in chronic hepatitis B patients with low estimated glomerular filtration rates;2024-06-25

2. Risk of hepatocellular carcinoma after curative treatment when switching from tenofovir disoproxil fumarate or entecavir to tenofovir alafenamide: A real‐world multicenter cohort study;Hepatology Research;2024-02

3. Application of Tenofovir Alafenamide Fumarate in Patients with Chronic Hepatitis B;Advances in Clinical Medicine;2024

4. Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022);Journal of Clinical and Translational Hepatology;2023-08-15

5. Perspectives on the Underlying Etiology of HCC and Its Effects on Treatment Outcomes;Journal of Hepatocellular Carcinoma;2023-03